Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (351-360 of 397) with videos related to

Pageof 40
Sort By:
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
BMJ Open|March 2, 2024
Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural AppalachiaApril M Young, Jennifer R Havens, Hannah L F Cooper, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
BMJ Global Health|February 25, 2021
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in MyanmarLara K Marquez, Antoine Chaillon, Kyi Pyar Soe, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
AIDS (London, England)|July 2, 2024
The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d'Ivoire, Mali, and SenegalRomain Silhol, Mathieu Maheu-Giroux, Nirali Soni, et al.
The Lancet. HIV|March 5, 2026
The impact of HIV stigma and discrimination on HIV testing, antiretroviral treatment, and viral suppression in Africa: a pooled analysis of population-based surveysCarla M Doyle, Salome Kuchukhidze, James Stannah, et al.
The Lancet. Gastroenterology & Hepatology|March 27, 2026
The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global reportFuqiang Cui, Diana Faini, Devin Razavi-Shearer, et al.
Pageof 40

Showing results (351-360 of 397) with videos related to

Sort By:
Pageof 40
Health Technology Assessment (Winchester, England)|February 3, 2026
The impact and cost-effectiveness of scaling up HCV treatment for achieving elimination among people who inject drugs in England: a synopsis including evidence synthesis and economic modellingZoe Ward, Ruth Simmons, Hannah Fraser, et al.
The Lancet. Gastroenterology & Hepatology|February 17, 2024
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictionsAlison D Marshall, Alex R Willing, Abe Kairouz, et al.
BMJ Open|March 2, 2024
Kentucky Outreach Service Kiosk (KyOSK) Study protocol: a community-level, controlled quasi-experimental, type 1 hybrid effectiveness study to assess implementation, effectiveness and cost-effectiveness of a community-tailored harm reduction kiosk on HIV, HCV and overdose risk in rural AppalachiaApril M Young, Jennifer R Havens, Hannah L F Cooper, et al.
The Lancet Regional Health. Europe|January 6, 2025
Impact and cost-effectiveness of scaling up HCV testing and treatment strategies for achieving HCV elimination among people who inject drugs in England: a mathematical modelling studyZoe Ward, Ruth Simmons, Hannah Fraser, et al.
BMJ Global Health|February 25, 2021
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in MyanmarLara K Marquez, Antoine Chaillon, Kyi Pyar Soe, et al.
The International Journal on Drug Policy|June 22, 2025
Impact and cost-effectiveness of interventions to eliminate hepatitis C virus among people who inject drugs in Haiphong, VietnamAdam Trickey, Josephine G Walker, Pham Minh Khue, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
AIDS (London, England)|July 2, 2024
The impact of past HIV interventions and diagnosis gaps on new HIV acquisitions, transmissions, and HIV-related deaths in Côte d'Ivoire, Mali, and SenegalRomain Silhol, Mathieu Maheu-Giroux, Nirali Soni, et al.
The Lancet. HIV|March 5, 2026
The impact of HIV stigma and discrimination on HIV testing, antiretroviral treatment, and viral suppression in Africa: a pooled analysis of population-based surveysCarla M Doyle, Salome Kuchukhidze, James Stannah, et al.
The Lancet. Gastroenterology & Hepatology|March 27, 2026
The burden of chronic hepatitis B and C in 2022 and progress towards elimination: a global reportFuqiang Cui, Diana Faini, Devin Razavi-Shearer, et al.
Pageof 40